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ABSTRACT
Background: Helicobacter pylori (H. pylori) infection is the main cause of peptic ulcer disease, gastric 
mucosa metaplasia, and gastric malignancy. The hypothesis of this study is whether there’s an association 
between metaplasia and gastric malignancy with H. pylori infection. 
Method: We conducted a retrospective study on 1,127 dyspepsia subjects who performed endoscopy between 
2001 to 2011 at a hospital in North Jakarta. Data is obtained based on endoscopy and histopathology data. 
Investigation of H. pylori in this study using histopathology examination. 
Results: Of the 1,127 dyspepsia subjects who performed endoscopy and biopsy, there were 130 (11.54%) H. 
pylori-positive subjects. Gender proportion was composed of 55.37% men and 44.63% women, with median 
age was 47 years. On the histopathology examination, we obtained 45 metaplasia subjects with median age of 
45 years and 7 malignancy subjects with median age of 64 years. Metaplasia was found in 33 of 997 (3.31%) 
H. pylori-negative subjects and 12 of 130 (9.23%) H. pylori-positive subjects. All gastric malignancy subjects 
had H. pylori-negative results.
Conclusion: There was an association between metaplasia and H. pylori infection, but no association between 
gastric malignancy and H. pylori infection.
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ABSTRAK
Latar belakang: Infeksi Helicobacter pylori (H. pylori) adalah penyebab utama penyakit ulkus peptikum, 
metaplasia mukosa lambung, dan keganasan lambung. Hipotesis studi ini adalah apakah terdapat hubungan 
antara metaplasia dan keganasan lambung dengan infeksi H. pylori.
Metode: Kami melakukan studi retrospektif terhadap 1.127 subyek dyspepsia yang dilakukan endoskopi 
antara tahun 2001-2011 di rumah sakit di Jakarta Utara. Data didapatkan berdasarkan data endoskopi dan 
histopatologi. Pemeriksaan H. pylori pada penelitian ini menggunakan pemeriksaan histopatologi. 
Hasil: Dari 1.127 subyek dyspepsia yang dilakukan endoskopi dan biopsi, terdapat 130 (11,54%) subyek 
positif H. pylori. Proporsi jenis kelamin didapatkan 55,37% laki-laki dan 44,63% perempuan dengan median 
usia 47 tahun. Pada pemeriksaan histopatologi, kami mendapatkan 45 subyek dengan gambaran metaplasia 
dengan median usia 45 tahun dan 7 subyek mengalami keganasan lambung dengan median usia 64 tahun. 
Metaplasia didapatkan pada 33 dari 997 (3,31%) subyek negatif H. pylori dan 12 dari 130 (9,23%) subyek 
positif H. pylori. Semua subyek keganasan lambung memberikan hasil H. pylori yang negatif.
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Simpulan: Terdapat hubungan antara metaplasia dengan infeksi H. pylori, tetapi tidak ada hubungan antara 
keganasan lambung dengan infeksi H. pylori.
Kata Kunci: metaplasia, keganasan lambung, infeksi H. pylori, studi retrospektif
INTRODUCTION
H. pylori is one of the most common infections 
in human. This infection is associated with a number 
of important conditions in the upper gastrointestinal 
tract, such as chronic gastritis, peptic ulcer disease 
(PUD), and gastric malignancy. The prevalence of H. 
pylori tends to be related to socioeconomic conditions, 
therefore the infection is more prevalent in developing 
countries.1 The prevalence of H. pylori in developed 
countries is generally below than 40% and this number 
is dominated by adults and elderly.2 In Asia, the 
prevalence of H. pylori infection ranges from 54% 
to 76%.3 Each year, about 990,000 individuals in the 
world are diagnosed with gastric malignancy, and 
738,000 of them die. This causes gastric malignancy 
is in the fourth position as the most common cancer, 
and the second position as most common cause of 
cancer death.4 
Gastric malignancy usually develops due to 
mucosal changes from non-atrophic gastritis to 
atrophic gastritis, intestinal metaplasia and dysplasia, 
and adenocarcinoma. Atrophic gastritis and intestinal 
metaplasia may be considered as a pre-neoplastic 
gastric lesion. H. pylori infection is the first step in the 
presence of gastric carcinogenesis cascade.5 Several 
studies hypothesize that treatment of H. pylori may 
prevent the development of intestinal metaplasia 
into gastric adenocarcinoma. There is no definitive 
population data suggesting that H. pylori eradication 
can decrease the incidence of gastric adenocarcinoma.1 
The hypothesis of this study is whether there is an 
association between metaplasia and gastric malignancy 
with H. pylori infection.
METHOD
This retrospective study was conducted in hospitals 
at North Jakarta between 2001-2011. A total of 1.127 
subjects, who underwent endoscopy, with complaints 
of dyspepsia, defined as pain or discomfort centered in 
the upper abdomen and lasting for one month or more, 
were included in the study. Subjects with a history 
of gastrointestinal surgery were excluded. Informed 
consent is obtained from subjects who will undergo 
endoscopic examination. All endoscopic examinations 
are performed by endoscopic expert. Endoscopic 
findings are evaluated, such as macroscopic changes, 
i.e. erythema, erosion, mucosal defects, absence of 
rugae, or bleeding spots.
The data taken are endoscopic and histopathology 
data from research subjects. In this study, H. pylori 
examination used histopathological examination. The 
biopsy sample was examined in anatomical pathology 
department. Data were entered and analyzed using 
statistical package for social science (SPSS) for windows 
version 16.0. The analysis was done using Chi-square 
test to determine the association between metaplasia 
and gastric malignancy, and H. pylori infection. A 
statistically significant level was defined as p < 0,05.
RESULTS
Total of 1.127 of dyspepsia subjects were enrolled 
in the study and the median age of the subjects was 47 
years old. The proportion of gender was 55.37% (n = 
624) men and 44.63% (n = 503) women. Out of 1.127 
subjects, 130 (11.54%) were positive and 997 (88.46%) 
were negative for H. pylori infection. Table 1 describes 
the characteristics among subjects enrolled in the study. 
Table 1. Characteristics of patients with and without H. pylori 
infection
Sex Total H. pylori-positiven (%)
H. pylori-negative
n (%)
Sex
Men 624 78 (12.5) 546 (87.5)
Women 503 52 (10.34) 451 (89.66)
Age
< 40 394 44 (11.17) 350 (88.83)
40-59 436 53 (12.16) 383 (87.84)
> 60 297 33 (11.11) 264 (88.89)
Total 1.127 130 (11.54) 997 (88.46)
A comparison of histologic findings between two 
groups is explained in Table 2. A significant association 
was observed between H. pylori-positive infection and the 
intestinal metaplasia findings (p < 0,05). We obtained 45 
subjects have metaplasia with a median age of 45 years 
and 7 subjects have gastric malignancy with a median age 
of 64 years. Metaplasia was found in 33 of 997 (3.31%) H. 
pylori-negative subjects and 12 of 130 (9.23%) H. pylori-
positive subjects. All subjects of gastric malignancy were 
found have negative H. pylori infection. We found that 
there were no association between gastric malignancy 
and H. pylori infection (p > 0.05).
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Table 2. Histologic findings of patients with and without H. 
pylori infection
H. pylori-positive
n (%)
H. pylori-negative
n (%)
Intestinal metaplasia
Absence 118 (10,91) 964 (89.09)
Presence 12 (26,67) 33 (73,33)
Gastric malignancy 0 (0) 7 (100)
Subjects with metaplasia and gastric malignancy 
were dominated by men, i.e. 57.8% and 57.1%. Intestinal 
metaplasia and gastric malignancy are more common 
in elderly subjects, i.e. 51.1% and 71.4% (Table 3). 
A strongly significant positive association was noted 
between histologic findings (intestinal metaplasia and 
gastric malignancy) and elderly (p < 0.05).
Previous study reported that H. pylori infection 
rates increase with age, i.e. 51.6% at age around 30 
years and 70% at age above 60 years.16 Ohkuma et al 
explained that the prevalence of intestinal metaplasia 
increased significantly in elderly (OR = 5.5) with H. 
pylori infection.7
Geographical data affect the prevalence of H. 
pylori and incidence of gastric malignancy. H. pylori 
colonization is estimated to increase the risk of gastric 
malignancy by tenfold.2 The development of gastric 
malignancy consists of several stages, i.e. inflammation 
of gastric mucosa associated with H. pylori infection, 
atrophic gastritis, intestinal metaplasia, dysplasia, and 
intestinal type gastric malignancy.9 The histologic 
developmental mechanisms remain unknown.14 
Intestinal metaplasia is defined as the replacement 
of gastric columnar epithelial cells into intestinal 
morphological cells, which is characterized by goblet 
cells, Paneth cells, and absorptive cells.8 Point of 
no return can occur in the histological cascade of 
chronic gastritis to adenocarcinoma, where H. pylori 
eradication can’t prevent gastric malignancy occurring 
in this condition. A meta-analysis of 12 studies 
conducted on 2,658 patients concluded that H. pylori 
eradication had an impact on improvements in gastric 
corpus atrophy, but did not have any effect on intestinal 
metaplasia. However, H. pylori elimination is still a 
promising strategy for reducing the incidence of gastric 
malignancy.13 Leung et al concluded that H. pylori 
eradication has a protective effect in progression to a 
pre-neoplastic gastric lesion in Chinese populations.1 
Study that involved 1,526 Japanese populations 
provide evidence that H. pylori infection significantly 
increases the risk of gastric malignancy. Uemura et al 
reported that gastric malignancy can develop in about 
3% of subjects infected with H. pylori, compared 
with uninfected subjects.20 H. pylori eradication may 
significantly reduce the risk of gastric malignancy 
in infected subjects, with no gastric pre-neoplastic 
lesions.13,20 Diagnosis of gastric pre-neoplastic lesions, 
such as atrophic gastritis and intestinal metaplasia, of 
endoscopy results are helpful for individuals at high 
risk of gastric malignancy. Health check-up endoscopy 
is a well-known screening test for gastric malignancy.9
In our study, there was a gastric malignancy of the 
subjects with a negative H. pylori infection. Some 
studies described about H. pylori-negative gastric 
cancers (HpNGC) cases, and the prevalence was about 
0.42-5.4% of the gastric malignancy total insidence.17 
The prevalence of HpNGC is found to be very low in 
the Japanese population (0.66%), with pathological 
Table 3. Histologic findings of patients based on gender and age
Metaplasia
n (%)
Gastric malignancy
n (%)
Sex
Men 26 (57,8) 4 (57,1)
Women 19 (42,2) 3 (42,9)
Age
< 40 9 (20) 0 (0)
40-59 13 (28,9) 2 (28,6)
> 60 23 (51,1) 5 (71,4)
Total 45 (100) 7 (100)
DISCUSSION
Colonization of H. pylori is not a stand-alone 
disorder, but it is a condition that causes a relative risk 
to the development of various clinical disorders that 
vary from upper gastrointestinal tract to hepatobiliary 
tract.2 The incidence of H. pylori infection varies 
in different countries of the world.6 Study about H. 
pylori also conducted in Yogyakarta that involved 92 
subjects. There were 22.8% of subjects with H. pylori 
infection.21 
Our study found that the prevalence of subjects 
with H. pylori infection dominated by men, i.e. 60% 
(n = 78). This finding agreed with previous reports. 
Based on 18 large studies, De Martel et al concluded 
that H. pylori infection are more common in men 
than women.10 Another study by Sasidharan et al also 
explained that prevalence rate of H. pylori infection 
on Malaysian patients was higher in men (51.9%).15
We found an association between H. pylori infection 
with an intestinal metaplasia in our study subjects (p < 
0.05). Previous study conducted in Korea evidence a 
higher prevalence of intestinal metaplasia in subjects 
with H. pylori infection (44.3%).8 
Intestinal metaplasia is more common in our elderly 
subjects (51.1%). Intestinal metaplasia appears to be 
caused by either aging, process and result of H. pylori 
infection, or both of them.7 Progression H. pylori 
infection to intestinal metaplasia usually occurs in the 
elderly due to long periods of H. pylori infection.11 
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characteristics distinct from gastric malignancy in 
general.18 Kato et al reports that a small proportion 
of patients with gastric malignancy indicates a 
multifactorial carcinogen without H. pylori infection. 
This indicates that gastric malignancy can still exist 
without H. pylori infection, with an incidence of 
2-10.6%.19 
Diagnostic criteria for HpNGC vary greatly among 
case reports, and have not been definitively defined. 
Etiology of gastric malignancy, in addition to H. pylori 
infection, is usually associated with several factors, 
such as lifestyle, viral infections, autoimmune diseases, 
and germline mutations. Nevertheless, the main factor 
causing HpNGC remains unclear.17 
This study also has limitations. The location of 
endoscopy and severity has not been classified. In 
additional, patients with metaplasia and H. pylori-
negative infection have either had a previous H. pylori 
infection or currently have an ongoing infection, 
even though no bacteria were found in the histologic 
analyses. The large amount of analytical experience 
from endoscopic experts can also help increase the rate 
of detection of intestinal metaplasia in future studies.
CONCLUSION
There was an association between metaplasia and 
H. pylori infection, but no association between gastric 
malignancy and H. pylori infection. Further research 
with a larger sample or case series that includes 
subjects with gastric malignancy is needed to provide 
evidence regarding the association between these two 
things. 
REFFERENCES
1. Chey WD, Wong BCY. American College of Gastroenterology 
Guideline on the Management of Helicobacter pylori 
Infection. Am J Gastroenterol 2007;102:1808-25.
2. Kusters JG, van Vliet AHM, Kuipers EJ. Pathogenesis 
of Helicobacter pylori Infection. Clin Microbiol Rev 
2006;19:449-90.
3. Eusebi LH, Zagari RM, Bazzoli F. Epidemiology of 
Helicobacter pylori Infection. Helicobacter 2014;19:1-5.
4. Karimi P, Islami F, Anandasabapathy S, Freedman ND, 
Kamangar F. Gastric cancer: descriptive epidemiology, 
risk factors, screening, and prevention. Cancer Epidemiol 
Biomarkers Prev 2014;23:700-13. 
5. Liu KSH, Wong IOL, Leung WK. Helicobacter pylori 
associated gastric intestinal metaplasia: treatment and 
surveillance. World J Gastroenterol 2016;22:1311-20.
6. Topal D, Goral V, Yilmaz F, Kara IH. The relation of 
Helicobacter pylori with intestinal metaplasia, gastric atrophy, 
and BCL-2. Turk J Gastroenterol 2004; 15:149-55.
7. Ohkuma K, Okada M, Murayama H, Seo M, Maeda K, Kanda 
M, et al. Association of Helicobacter pylori infection with 
atrophic gastritis and intestinal metaplasia. J Gastroenterol 
Hepatol 2000;15:1105-12.
8. Kim HJ, Choi BY, Byun TJ, Eun CS, Song KS, Kim YS, et al. 
The prevalence of atrophic gastritis and intestinal metaplasia 
according to gender, age, and Helicobacter pylori infection in 
a rural population. J Prev Med Public Health 2008; 41:373-9.
9. Joo YE, Park HK, Myung DS, Baik GH, Shin JE, Seo GS, 
et al. Prevalence and risk factors of atrophic gastritis and 
intestinal metaplasia: a nationwide multicenter prospective 
study in Korea. Gut and Liver 2013;7:303-10.
10. De Martel C, Parsonnet J. Helicobacter pylori infection 
and gender: a meta-analysis of population-based prevalence 
surveys. Dig Dis Sci 2006;51:2292-301.
11. Asaka M, Sugiyama T, Nobuta A, Kato M, Takeda H, 
Graham DY. Atrophic gastritis and intestinal metaplasia 
in Japan: results of a large multicenter study. Helicobacter 
2001;6:294-9.
12. Malfertheiner P, Peitz U. The Interplay between Helicobacter 
pylori, Gastro-oesophageal Reflux Disease, and Intestinal 
Metaplasia. Gut 2005;54:i13-i20.
13. Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon 
ATR, Bazzoli F, et al. Management of Helicobacter pylori 
infection – The Maastricht IV/Florence Consensus Report. 
Gut 2012;61:646-64.
14. Serizawa T, Hirata Y, Hayakawa Y, Suzuki N, Sakitani K, 
Hikiba Y, et al. Gastric metaplasia induced by Helicobacter 
pylori is associated with enhanced SOX9 expression via 
interleukin-1 signaling. Infect Immun 2016;84:562-72.
15. Sasidharan S, Ghayethry B, Ravichandran M, Latha LY, 
Lachumy SJ, Leng KM, et al. Prevalence of Helicobacter 
pylori infection among patients referred for endoscopy: gender 
and ethnic differences in Kedah, Malaysia. Asian Pac J Trop 
Dis 2012;55-9.
16. Marusic M, Barac KM, Bilic A, Jurcic D, Gulic S, Rotkvic 
PG, et al. Do gender and age influence the frequency of 
Helicobacter pylori infection? Wien Klin Wochenschr 
2013;125:714-6.
17. Yamamoto Y, Fujisaki J, Omae M, Hirasawa T, Igarashi M. 
Helicobacter pylori-negative gastric cancer: characteristics 
and endoscopic findings. Dig Endosc 2015;27:551-61.
18. Matsuo T, Ito M, Takata S, Tanaka S, Yoshihara M, Chayama 
K. Low prevalence of Helicobacter pylori-negative gastric 
cancer among Japanese. Helicobacter 2011;16:415-9.
19. Kato S, Matsukura N, Tsukada K, Matsuda N, Mizoshita T, 
Tsukamoto T, et al. Helicobacter pylori infection-negative 
gastric cancer in Japanese hospital patients: incidence and 
pathological characteristics. Cancer Sci 2007;98:790-4.
20. Wroblewski LE, Peek RM, Wilson KT. Helicobacter pylori 
and gastric cancer: factors that modulate disease risk. Clin 
Microbiol Rev 2010;713-39.
21. Bayupurnama P, Nurdjanah S. Histopathological pattern of 
gastric biopsies of Helicobacter pylori positive patients in 
Sardjito General Hospital Yogyakarta. Indones J Gastroenterol 
Hepatol Dig Endosc 2000;1:2-4.
22. Syam AF. Dyspepsia and Helicobacter pylori infection. 
Indones J Gastroenterol Hepatol Dig Endosc 2013;14:1-2.
